ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about the drug pricing provisions currently being considered in spending bill negotiations and how they would impact the payment & reimbursement of drugs.

September 30, 2021 BACK TO RESOURCES

ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about the drug pricing provisions currently being considered in spending bill negotiations and how they would impact the payment & reimbursement of drugs.
Read more